Inflammation-induced PINCH expression leads to actin depolymerization and mitochondrial mislocalization in neurons

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Chronic neuroinflammation is linked to metabolic changes in the central nervous system (CNS).
• Human immunodeficiency virus (HIV) and Alzheimer's disease (AD) patients exhibit metabolic disturbances, but the mechanisms connecting inflammation, neurodegeneration, and energy deficits are unclear.
• The protein PINCH (particularly interesting new cysteine histidine-rich-protein) is highly expressed in neurodegenerative diseases like HIV and AD, but its role is poorly understood.

Purpose of the Study:

• To investigate the regulatory mechanisms of PINCH-mediated changes in neuronal bioenergetics and mitochondrial localization.
• To identify factors involved in actin depolymerization and mitochondrial mislocalization due to PINCH.
• To confirm PINCH specificity and restore protein complex communication using inhibition experiments.

Main Methods:

• Investigated PINCH protein-mediated effects on bioenergetics and mitochondrial localization in neurons exposed to TNFα or HIV Tat protein.
• Assessed changes in the PINCH-ILK-Parvin (PIP) complex association with cofilin and TESK1.
• Utilized lentiviral and pharmacological inhibition to confirm PINCH specificity and restore protein complex function.

Main Results:

• Identified MEF2A as the transcription factor for PINCH in neuroinflammation.
• Demonstrated that TNFα-induced MEF2A activation increases PINCH, disrupting the PIP complex, inactivating TESK1, and causing actin depolymerization.
• Showed that actin disruption leads to perinuclear mitochondrial mislocalization, impairing neuronal metabolism; blocking PINCH expression preserved mitochondrial localization and metabolism.

Conclusions:

• This study elucidates the mechanistic and biological consequences of PINCH expression in CNS neurons during chronic neuroinflammation.
• Findings highlight the potential of maintaining physiological PINCH levels as a therapeutic target for neurodegenerative diseases with metabolic dysfunction.